Burkett Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$37.7K Sell
144
-84
-37% -$21.5K 0.01% 183
2026
Q2
$57.5K Buy
228
+2
+0.9% +$430 0.02% 89
2026
Q1
$49.3K Buy
226
+1
+0.4% +$222 0.02% 100
2025
Q4
$51.4K Buy
225
+2
+0.9% +$456 0.02% 95
2025
Q3
$51.7K Buy
223
+1
+0.5% +$204 0.02% 92
2025
Q2
$41.1K Buy
222
+2
+0.9% +$372 0.01% 101
2025
Q1
$46K Buy
220
+2
+0.9% +$389 0.02% 94
2024
Q4
$38.7K Buy
218
+2
+0.9% +$368 0.02% 99
2024
Q3
$42.6K Buy
216
+82
+61% +$15.3K 0.02% 86
2024
Q2
$23K Buy
134
+1
+0.8% +$166 0.01% 110
2024
Q1
$24.2K Buy
133
+1
+0.8% +$172 0.01% 112
2023
Q4
$20.4K Buy
+132
New +$19.2K 0.01% 114

Other funds holding ABBV

Burkett Financial Services's ABBV Position: Q3 2026 in Review

Burkett Financial Services reduced its AbbVie (ABBV) stake by 37% in Q3 2026, selling an estimated $21.5K and leaving 144 shares worth $37.7K. The position accounts for 0.01% of the portfolio, ranked #183.

Burkett Financial Services first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. The position peaked at $57.5K in Q2 2026. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Burkett Financial Services held 144 shares of AbbVie worth $37.7K as of Q3 2026.
  • Burkett Financial Services sold 84 AbbVie shares in Q3 2026, an estimated $21.5K.
  • AbbVie made up 0.01% of Burkett Financial Services's portfolio in Q3 2026, its #183 holding.
  • Burkett Financial Services first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • Burkett Financial Services's AbbVie position peaked at $57.5K in Q2 2026.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Burkett Financial Services's 13F filing for Q3 2026, filed 1 Oct 2026.